Rencofilstat, a pan-cyclophilin inhibitor, exerts diverse metabolic and transcriptional anti-tumor activities in a murine NASH-HCC modelDaren Ure, Philippe Gallay, Joseph Kuo et al.|Journal of Hepatology|2022Cited by 0
Cyclophilin inhibition with rencofilstat shifts the liver transcriptome and lipidome in preclinical models toward resolution of non-alcoholic steatohepatitisDaren Ure, Robert T. Foster, Patrick Mayo et al.|Journal of Hepatology|2023Cited by 0